Syndax Pharmaceuticals (SNDX) Short Interest Ratio & Short Volume → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free SNDX Stock Alerts $22.38 -0.80 (-3.45%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Syndax Pharmaceuticals Short Interest DataCurrent Short Volume9,600,000 sharesPrevious Short Volume9,620,000 sharesChange Vs. Previous Month-0.21%Dollar Volume Sold Short$207.55 millionShort Interest Ratio / Days to Cover8.3Last Record DateApril 15, 2024Outstanding Shares84,965,000 sharesPercentage of Shares Shorted11.30%Today's Trading Volume1,105,810 sharesAverage Trading Volume1,119,221 sharesToday's Volume Vs. Average99% Short Selling Syndax Pharmaceuticals ? Sign up to receive the latest short interest report for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNDX Short Interest Over TimeSNDX Days to Cover Over TimeSNDX Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself Syndax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20249,600,000 shares $207.55 million -0.2%N/A8.3 $21.62 3/31/20249,620,000 shares $228.96 million +15.5%N/A8.2 $23.80 3/15/20248,330,000 shares $195.92 million -8.4%N/A6.9 $23.52 2/29/20249,090,000 shares $213.07 million +5.7%N/A6.1 $23.44 2/15/20248,600,000 shares $194.96 million -1.0%N/A5.8 $22.67 1/31/20248,690,000 shares $178.06 million No ChangeN/A5.8 $20.49 Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,690,000 shares $193.27 million +3.7%N/A5.4 $22.24 12/31/20238,380,000 shares $181.09 million -19.0%N/A4.7 $21.61 12/15/202310,340,000 shares $214.76 million +1.1%N/A4.8 $20.77 11/30/202310,230,000 shares $170.28 million -3.7%N/A5.4 $16.65 11/15/202310,620,000 shares $159.94 million +6.4%N/A6.2 $15.06 10/31/20239,980,000 shares $140.52 million +17.4%N/A6.1 $14.08 10/15/20238,500,000 shares $101.92 million +12.1%N/A5.7 $11.99 9/30/20237,580,000 shares $110.06 million -0.1%N/A6 $14.52 9/15/20237,590,000 shares $131.76 million +9.1%N/A9.8 $17.36 8/31/20236,960,000 shares $128.83 million -2.8%N/A8.8 $18.51 8/15/20237,160,000 shares $132.03 million +7.7%N/A8.4 $18.44 7/31/20236,650,000 shares $141.78 million +12.1%N/A7.4 $21.32 7/15/20235,930,000 shares $125.42 million +3.3%N/A6.8 $21.15 6/30/20235,740,000 shares $120.14 million +2.5%N/A6.5 $20.93 6/15/20235,600,000 shares $119.45 million -10.0%N/A5.9 $21.33 5/31/20236,220,000 shares $124.21 million -2.7%N/A6.7 $19.97 5/15/20236,390,000 shares $135.15 million -2.0%N/A7.4 $21.15 4/30/20236,520,000 shares $133.99 million -5.2%N/A7.9 $20.55 4/15/20236,880,000 shares $137.60 million -9.8%N/A8.6 $20.00 3/31/20237,630,000 shares $161.15 million +12.4%N/A9.5 $21.12 3/15/20236,790,000 shares $151.42 million +13.4%N/A8.9 $22.30 2/28/20235,990,000 shares $151.85 million +8.5%N/A7 $25.35 2/15/20235,520,000 shares $143.46 million +0.6%N/A6.8 $25.99 1/31/20235,490,000 shares $157.56 million +0.6%N/A6.5 $28.70 1/15/20235,460,000 shares $143.65 million -14.3%N/A6.4 $26.31 12/30/20226,370,000 shares $162.12 million +22.5%N/A7.3 $25.45 12/15/20225,200,000 shares $125.84 million +17.7%N/A6.1 $24.20 11/30/20224,420,000 shares $105.90 million +5.7%N/A5.8 $23.96 11/15/20224,180,000 shares $91.46 million +2.7%N/A6 $21.88 10/31/20224,070,000 shares $93.45 million -9.2%N/A5.9 $22.96 10/15/20224,480,000 shares $105.41 million +0.9%9.4%6.7 $23.53 9/30/20224,440,000 shares $106.69 million -3.5%9.3%6.7 $24.03 9/15/20224,600,000 shares $113.02 million No Change9.6%7.2 $24.57 8/31/20224,600,000 shares $108.61 million +0.4%9.7%7 $23.61Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. SNDX Short Interest - Frequently Asked Questions What is Syndax Pharmaceuticals' current short interest? Short interest is the volume of Syndax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 9,600,000 shares of SNDX short. Learn More on Syndax Pharmaceuticals' current short interest. What is a good short interest ratio for Syndax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNDX shares currently have a short interest ratio of 8.0. Learn More on Syndax Pharmaceuticals's short interest ratio. Which institutional investors are shorting Syndax Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Syndax Pharmaceuticals: Simplex Trading LLC, Frazier Life Sciences Management L.P., and Worth Venture Partners LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Syndax Pharmaceuticals' short interest increasing or decreasing? Syndax Pharmaceuticals saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 9,600,000 shares, a decrease of 0.2% from the previous total of 9,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Syndax Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Syndax Pharmaceuticals: Edgewise Therapeutics, Inc. (9.15%), NewAmsterdam Pharma (0.85%), Amneal Pharmaceuticals, Inc. (2.51%), Galapagos NV (2.30%), Amphastar Pharmaceuticals, Inc. (11.01%), Agios Pharmaceuticals, Inc. (12.15%), Structure Therapeutics Inc. (9.92%), Deciphera Pharmaceuticals, Inc. (11.45%), Keros Therapeutics, Inc. (6.27%), Evotec SE (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Syndax Pharmaceuticals stock? Short selling SNDX is an investing strategy that aims to generate trading profit from Syndax Pharmaceuticals as its price is falling. SNDX shares are trading down $0.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Syndax Pharmaceuticals? A short squeeze for Syndax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNDX, which in turn drives the price of the stock up even further. How often is Syndax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNDX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: EWTX Short Squeeze NAMS Short Squeeze AMRX Short Squeeze GLPG Short Squeeze AMPH Short Squeeze AGIO Short Squeeze GPCR Short Squeeze DCPH Short Squeeze KROS Short Squeeze EVO Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNDX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders